NY
United States
Memorial Sloan Kettering Cancer Center - Department of Surgery
Immune Checkpoint Inhibitors; Immunotherapy; Neutrophil-to-Lymphocyte Ratio; Biomarkers
Immune Checkpoint Blockade, Immuno-Oncology Therapy, Cancer, Genomics, Meta-analysis, Machine Learning, Scientific Software
HNSCC, Immunotherapy, prognostic significance, survival, PD-L1 expression